Search Within

Christopher Riedl

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (9)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (29)
  2. Radiology, Department of (29)
  3. Sloan Kettering Institute Postdocs (29)
  4. Center for Pancreatic Cancer Research (11)
  5. GSK Faculty (10)
  6. Biostatistics Service (9)

More Groups

People
  1. Katja Pinker-Domenig (14)
  2. Gary Ulaner (11)
  3. Wolfgang Weber (10)
  4. Leonard Ong (7)
  5. Maxine Jochelson (7)
  6. Maura Dickler (6)

More People

Years
  1. 2022 (3)
  2. 2021 (2)
  3. 2020 (6)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (3)

More Years

Publications
  1. Journal of Nuclear Medicine (9)
  2. European Journal of Nuclear Medicine and Molecular Imaging (4)
  3. Journal of Clinical Oncology (3)
  4. CardioVascular and Interventional Radiology (2)
  5. Clinical Nuclear Medicine (1)
  6. Clinical and Translational Imaging (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (9)
  2. Springer (7)
  3. American Society of Clinical Oncology (3)
  4. Lippincott Williams & Wilkins (2)
  5. Oxford University Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact that number of analyzed metastatic breast cancer lesions has on response assessment by (18)F-FDG PET/CT using PERCIST
    Journal Article

    Pinker, K.; Riedl, C. C.; Ong, L.; Jochelson, M.; Ulaner, G. A.; McArthur, H.; Dickler, M.; Gönen, M.; Weber, W. A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of SUVmax and SUVpeak for response assessment in stage 4 non-small cell lung cancer (NSCLC) by FDG PET/CT
    Meeting Abstract

    Ong, L.; Rager, O.; Lohrmann, C.; Riedl, C.; Pinker, K.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Human Cerenkov imaging using 18F-FDG - Reply
    Journal Article

    Thorek, D. L.; Riedl, C. C.; Grimm, J.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Clinical Cerenkov luminescence imaging of (18)F-FDG
    Journal Article

    Thorek, D. L.; Riedl, C. C.; Grimm, J.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model
    Journal Article

    Brader, P.; Riedl, C. C.; Woo, Y.; Ponomarev, V.; Zanzonico, P.; Wen, B.; Cai, S.; Hricak, H.; Fong, Y.; Blasberg, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save